Clinical Decision Support to Reduce Catheter Associated Urinary Tract Infections
Randomized, Controlled Evaluations of the Effectiveness of Clinical Decision Support Systems (REEDS)
1 other identifier
interventional
79,369
1 country
8
Brief Summary
The goal of this randomized controlled trial is to compare the effects of a clinical decision support tool consisting of a 48-hour stop order for indwelling urinary catheters versus no clinical decision support in hospitalized patients with indwelling urinary catheters. The main questions it aims to answer are: \- Does the presence of an automated stop order integrated as part of a clinical decision support tool reduce dwell time of urinary catheters and the rate of catheter associated urinary tract infections? Participants who have indwelling urinary catheters ordered will be randomized to either have these orders automatically expire after 48 hours unless an action is taken or have orders without expiration. Researchers will compare the urinary catheter dwell time and the rate of catheter associated urinary tract infections between the two groups.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Aug 2021
8 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 17, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 4, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
April 4, 2023
CompletedFirst Submitted
Initial submission to the registry
June 6, 2024
CompletedFirst Posted
Study publicly available on registry
June 12, 2024
CompletedJune 20, 2024
June 1, 2024
1.6 years
June 6, 2024
June 17, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Urinary catheter dwell time
The time between urinary catheter insertion and removal
Measured from time of catheter insertion until catheter removal or hospital discharge if the catheter was not removed, up to 250 days.
Secondary Outcomes (3)
Catheter Associate Urinary Tract Infection (CAUTI) rate
The development of a CAUTI was assessed from time of catheter insertion until either catheter removal or hospital discharge if the catheter was not removed, up to 250 days.
CAUTI population rate
The development of a CAUTI was assessed from time of catheter insertion until either catheter removal or hospital discharge if the catheter was not removed, up to 250 days.
CAUTI Free survival
The development of a CAUTI was assessed from time of catheter insertion until either catheter removal or hospital discharge if the catheter was not removed, up to 250 days.
Study Arms (2)
Stop Orders
EXPERIMENTALFor participants in this arm, a clinical decision support tool consisting of stop orders and an expiring alert that was displayed to care team clinicians.
Continuous Orders
NO INTERVENTIONFor participants in this arm, no clinical decision support or alerts were displayed to care team clinicians and the urinary catheter order was continuous.
Interventions
A 48 hour expiration on orders placed for indwelling urinary catheters.
Eligibility Criteria
You may qualify if:
- Admitted to hospital
- At least 18 years old
- Has order placed for indwelling urinary catheter
You may not qualify if:
- Indication for urinary catheter labeled as either "Chronic" or "Placed by urology"
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (8)
NewYork-Presbyterian Westchester
Bronxville, New York, 10708, United States
NewYork-Presbyterian Brooklyn Methodist Hospital
Brooklyn, New York, 11215, United States
NewYork-Presbyterian Hudson Valley Hospital
Cortlandt Manor, New York, 10567, United States
NewYork-Presbyterian Queens
Flushing, New York, 11355, United States
NewYork-Presbyterian Columbia University Irving Medical Center
New York, New York, 10032, United States
NewYork-Presbyterian Allen Hospital
New York, New York, 10034, United States
NewYork-Presbyterian Lower Manhattan Hospital
New York, New York, 10038, United States
NewYork-Presbyterian Weill Cornell Medical Center
New York, New York, 10065, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jason Adelman, MD, MS
Columbia University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 6, 2024
First Posted
June 12, 2024
Study Start
August 17, 2021
Primary Completion
April 4, 2023
Study Completion
April 4, 2023
Last Updated
June 20, 2024
Record last verified: 2024-06
Data Sharing
- IPD Sharing
- Will not share